Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4469396
Max Phase: Preclinical
Molecular Formula: C31H28F3IN6O6
Molecular Weight: 764.50
Molecule Type: Unknown
Associated Items:
ID: ALA4469396
Max Phase: Preclinical
Molecular Formula: C31H28F3IN6O6
Molecular Weight: 764.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C1CCC(N2C(=O)c3cccc(NCCNCCCONC(=O)c4ccc(F)c(F)c4Nc4ccc(I)cc4F)c3C2=O)C(=O)N1
Standard InChI: InChI=1S/C31H28F3IN6O6/c32-19-7-6-18(27(26(19)34)38-21-8-5-16(35)15-20(21)33)28(43)40-47-14-2-11-36-12-13-37-22-4-1-3-17-25(22)31(46)41(30(17)45)23-9-10-24(42)39-29(23)44/h1,3-8,15,23,36-38H,2,9-14H2,(H,40,43)(H,39,42,44)
Standard InChI Key: RRMNATGTRRMSTA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 764.50 | Molecular Weight (Monoisotopic): 764.1067 | AlogP: 3.61 | #Rotatable Bonds: 13 |
Polar Surface Area: 157.97 | Molecular Species: BASE | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 12 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.45 | CX Basic pKa: 9.25 | CX LogP: 4.96 | CX LogD: 3.12 |
Aromatic Rings: 3 | Heavy Atoms: 47 | QED Weighted: 0.08 | Np Likeness Score: -1.09 |
1. Wei J, Hu J, Wang L, Xie L, Jin MS, Chen X, Liu J, Jin J.. (2019) Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader., 62 (23): [PMID:31730343] [10.1021/acs.jmedchem.9b01528] |
2. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):